Characterization of E2F8-mediated transcriptional regulation in lethal prostate cancer
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 39 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 39 samples: 8 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancerOncogene · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE275631_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1152279 and SRA study SRP528595. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 27 samples.
How we read this: 8 replicated groups read from 39 sample titles; they account for 27 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8481307 PC3_IgG ChIP_rep1 PC3_IgG ChIP
- GSM8481308 PC3_IgG ChIP_rep2 PC3_IgG ChIP
- GSM8481309 PC3_IgG ChIP_rep3 PC3_IgG ChIP
- GSM8481310 PC3_E2F8 ChIP_rep1 PC3_E2F8 ChIP
- GSM8481311 PC3_E2F8 ChIP_rep2 PC3_E2F8 ChIP
- GSM8481312 PC3_E2F8 ChIP_rep3 PC3_E2F8 ChIP
- GSM8481313 DU145_IgG ChIP_rep1 DU145_IgG ChIP
- GSM8481314 DU145_IgG ChIP_rep2 DU145_IgG ChIP
- GSM8481315 DU145_IgG ChIP_rep3 DU145_IgG ChIP
- GSM8481316 DU145_E2F8 ChIP_rep1 DU145_E2F8 ChIP
- GSM8481317 DU145_E2F8 ChIP_rep2 DU145_E2F8 ChIP
- GSM8481318 DU145_E2F8 ChIP_rep3 DU145_E2F8 ChIP
- GSM8481319 PC3_siCtrl_rep1 72h
- GSM8481320 PC3_siCtrl_rep2 72h
- GSM8481321 PC3_siCtrl_rep3 72h
- GSM8481322 PC3_siE2F8_rep1 72h
- GSM8481323 PC3_siE2F8_rep2 72h
- GSM8481324 PC3_siE2F8_rep3 72h
- GSM8481325 DU145_siCtrl_rep1 72h
- GSM8481326 DU145_siCtrl_rep2 72h
- GSM8481327 DU145_siCtrl_rep3 72h
- GSM8481328 DU145_siE2F8_rep1 72h
- GSM8481329 DU145_siE2F8_rep2 72h
- GSM8481330 DU145_siE2F8_rep3 72h
- GSM8481331 293FT_pre-gCtrl_rep1 293FT_pre-gCtrl
- GSM8481332 293FT_pre-gCtrl_rep2 293FT_pre-gCtrl
- GSM8481333 293FT_pre-gCtrl_rep3 293FT_pre-gCtrl
- GSM8481334 293FT_pre-gE2F8_rep1 293FT_pre-gE2F8
- GSM8481335 293FT_pre-gE2F8_rep2 293FT_pre-gE2F8
- GSM8481336 293FT_pre-gE2F8_rep3 293FT_pre-gE2F8
- GSM8481337 DU145 xeno_TT3 LLN-CasRx/pre-gCtrl_rep1 DU145 xeno_TT3 LLN-CasR…
- GSM8481338 DU145 xeno_TT3 LLN-CasRx/pre-gCtrl_rep2 DU145 xeno_TT3 LLN-CasR…
- GSM8481339 DU145 xeno_TT3 LLN-CasRx/pre-gCtrl_rep3 DU145 xeno_TT3 LLN-CasR…
- GSM8481340 DU145 xeno_TT3 LLN-CasRx/pre-gCtrl_rep4 DU145 xeno_TT3 LLN-CasR…
- GSM8481341 DU145 xeno_TT3 LLN-CasRx/pre-gCtrl_rep5 DU145 xeno_TT3 LLN-CasR…
- GSM8481342 DU145 xeno_TT3 LLN-CasRx/pre-gCtrl_rep6 DU145 xeno_TT3 LLN-CasR…
- GSM8481343 DU145 xeno_TT3 LLN-CasRx/pre-gE2F8_rep1 DU145 xeno_TT3 LLN-CasR…
- GSM8481344 DU145 xeno_TT3 LLN-CasRx/pre-gE2F8_rep2 DU145 xeno_TT3 LLN-CasR…
- GSM8481345 DU145 xeno_TT3 LLN-CasRx/pre-gE2F8_rep3 DU145 xeno_TT3 LLN-CasR…
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE270387 Single cell profiling of peripheral blood mononuclear cells in diverse men with prostate cancer reveals lethal disease-associated immune signatures 165 samples shares prostate, lethal
- GSE245969 EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells 122 samples shares prostate
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.